New treatment for ms. The use of advanced imaging markers .
New treatment for ms Now, the university is paving the way for an MS cure in our lifetimes. This breakthrough could potentially shift the therapeutic focus from managing symptoms to actively promoting repair and regeneration Jun 6, 2025 · The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. Feb 21, 2024 · Research for progressive types of MS over the past decade has led to important treatment and clinical trial milestones, a review study says. Multiple Sclerosis (MS) is a chronic disease in which the immune system mistakenly Jun 6, 2025 · A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over 2 years of follow-up with few adverse events. Nov 5, 2025 · SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial results show. Aug 8, 2025 · A wave of new treatments under investigation could reshape the landscape for multiple sclerosis (MS), particularly for patients with progressive forms of the disease—where current therapies fall Jul 24, 2024 · I was recently diagnosed with multiple sclerosis. Nov 1, 2024 · A comprehensive MS center is the best place for management of multiple sclerosis, and this typically includes physicians with expertise in multiple sclerosis, neurologists, but also urologists, physiatrists or physical medicine and rehabilitation providers, psychologists, and many other providers who have specialty interest in multiple sclerosis. The study summaries included in this edition of “What’s New in MS Research” highlight the broad spectrum of inquiry that is driving the progress to develop better treatments against the disease. Learn more about MS treatment advances and cure research. 2 days ago · Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, cutting the number of relapses compared to another treatment over Jul 28, 2025 · Though there’s no cure for multiple sclerosis, there are many new treatment options aimed at slowing its progression, decreasing symptoms, and improving mental and physical function. This can cause devastating problems with movement, balance and vision; and without treatment, it can lead to paralysis, loss of independence and a shortened lifespan. Gilenya Fingolimod, a drug manufactured by Novartis under the brand name Gilenya, is a U. Jan 5, 2024 · The FDA has cleared a Phase 2 clinical trial to test Kyverna's cell-based therapy KYV-101 for treatment-resistant forms of progressive MS. Jan 8, 2025 · CMSCTolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Designation is based on positive results from the HERCULES study in adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS) Tolebrutinib is the first and only brain-penetrant BTK inhibitor in MS to be designated Breakthrough Therapy by the FDA Paris 4 days ago · A NEW comparative study has found that cladribine provides greater protection against disability progression than sphingosine-1-phosphate receptor modulators in Treatment-Naive Relapsing-Remitting MS, while maintaining comparable relapse rates and MRI outcomes over a two-year period. 4. Apr 8, 2025 · Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for multiple sclerosis (MS). Aug 5, 2024 · A new drug, PIPE-307, shows promise in reversing multiple sclerosis (MS) damage by promoting myelin regeneration around nerve cells, potentially restoring movement and function. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of thi … Dec 16, 2024 · The details and timeline behind a novel approach to slowing the damage of multiple sclerosis that just got $1 million in funding. Jun 7, 2023 · The Race to Erase MS Forum and Expo highlighted new treatment techniques to combat relapsing-remitting and progressive MS. The researchers and clinicians who gathered in late February in West Palm Beach, Florida, for the 2025 ACTRIMS Forum shared data Aug 9, 2024 · Scientists have developed a new treatment that may help regenerate myelin around nerve cells, and potentially reverse the damage caused by multiple sclerosis (MS). Learn about MS clinical trials that could lead to the next breakthrough. . Years of May 22, 2025 · This edition of “What’s New in MS Research” includes a representative sampling of those presentations – a dozen items that cover everything from promising potential treatments and biomarkers that can help predict disease course, to insights into the unmet needs of people with MS and the factors that shape their decisions about disease-modifying therapies. Many of them are used to block the immune system's attack on the nerves and slow or prevent progression and relapses (flare-ups) of the disease. Mar 11, 2025 · Clinical trials in multiple sclerosis treatment at UNM Health mean our patients, our doctors, and our trainees are at the leading edge of groundbreaking advances. Feb 25, 2024 · Multiple Sclerosis is when myelin, a sheath under the nerve cells, is attacked by the body's immune system. Food and Drug Administration (FDA)-approved treatment for symptoms of relapsing forms of multiple sclerosis (MS). The clinical trials and other analyses to follow examine topics ranging from the Mar 27, 2025 · The annual meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is one of the premier occasions for the release of new studies on the nature and treatment of MS, and this year’s session continued that trailblazing tradition. 3 days ago · MS Minute: Update on BTK Inhibitors for Multiple Sclerosis—A New Treatment That Brings New Hope BTK inhibitors are the first class of medications to slow disability progression in secondary progressive multiple sclerosis without clinical relapses. Oct 21, 2025 · Several experimental treatments for multiple sclerosis are under the microscope. Nov 3, 2023 · While there is currently no cure for MS, there are effective treatments that can help manage the disease. While current treatments prevent further damage, the current findings may form the starting point for the development of new treatments for tissue recovery in MS. Sep 27, 2024 · This edition of “What’s New in MS Research” reflects the extent and breadth of efforts to better treat multiple sclerosis and to enhance the overall health of people living with the condition. DMTs can reduce the frequency and severity of MS Aug 6, 2024 · Multiple sclerosis (MS) degrades the protective insulation around nerve cells, leaving their axons, which carry electrical impulses, exposed like bare wires. Dec 29, 2022 · Briumvi joins Ocrevus and Kesimpta as the third anti-CD20 medication the FDA has approved for multiple sclerosis. However, progress has been made in developing new medicines to treat it. Are there any new treatments to help me fight this disease? There is no cure for multiple sclerosis… Jul 3, 2024 · There is no cure for multiple sclerosis (MS). Aug 28, 2023 · The FDA approved Tyruko (natalizumab), a biosimilar to previously-approved Tysabri, as a treatment for relapsing forms of multiple sclerosis. Jan 28, 2025 · A new year promises to bring a wealth of new insights into the nature and management of multiple sclerosis (MS). It is immunomodulatory in nature and works to reduce MS exacerbations and delay progression toward disability. The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. Others are used to manage resulting symptoms like pain, depression, and muscle Dec 29, 2024 · New interim data from the phase 3b ENHANCE trial (NCT05877963) of patients with multiple sclerosis (MS)demonstrated the tolerability of transitioning from treatment with intravenous (IV) anti-CD20 to ublituximab (Briumvi; TG Therapeutics), a novel monoclonal antibody approved therapy for relapsing forms of MS. Feb 5, 2025 · Medications are the mainstay of treatment for multiple sclerosis (MS). FDA approves Mayzent (cladribine), a new oral drug to treat multiple sclerosis Mar 24, 2025 · A new nasal spray treatment called foralumab may offer hope for those living with multiple sclerosis (MS). Jul 28, 2025 · In this edition of “What’s New in MS Research,” we highlight several of those studies, which provide encouraging data on investigational as well as therapies approved by the Food and Drug Administration, factors shaping clinician and patient decision-making regarding treatment, practical strategies for living with MS, and related topics. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental Jun 12, 2024 · A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Mass General Brigham researchers recently completed a phase 1 clinical trial of foralumab, which shows promise in reducing MS symptoms and improving the quality of life for those affected by this condition. The use of advanced imaging markers May 3, 2024 · In a groundbreaking study published in Cell on May 2, 2024, researchers have discovered a novel protein function inhibitor called ESI1 that can regenerate vital myelin coatings in mice mimicking multiple sclerosis (MS) symptoms and lab-prepared human brain cells. Nov 1, 2024 · What Are the Most Promising Experimental Treatments for Multiple Sclerosis? Researchers continue to search for new possibilities to cure MS—or at least better ways to manage the disease. Learn more about how it works. Affecting an estimated 2. May 19, 2025 · Medically Reviewed A New Drug Shows Promise in Treating Secondary Progressive MS The medication may be the first to help delay progression in more advanced forms of multiple sclerosis. Learn about its causes, implications & treatment options. 5 million people worldwide, MS leads to neurological impairments Oct 26, 2024 · There is no cure for multiple sclerosis (MS), but treatment like infusion therapy can improve your quality of life. One of the most impactful developments was the refinement of the McDonald diagnostic criteria, which embraced a biomarker-driven, molecular approach to viewing the disease. Learn how these breakthroughs could transform the lives of MS patients. Mar 11, 2025 · In 2024, the field of multiple sclerosis (MS) witness significant advancements in both diagnostic capabilities and treatment options, signaling a transformative year for patient care. Research is ongoing to develop new and better disease-modifying therapies (DMTs) for this disease of the central nervous system. A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential drug targets for the treatment of multiple sclerosis. May 26, 2025 · Remyelination in MS: Scientists Uncover Promising Treatment Pathway Introduction Multiple sclerosis(MS) research has entered a transformative phase with the emergence of two promising therapies aimed at restoring myelin, the protective sheath around nerve fibers that is progressively damaged in MS. The study may pave Aug 26, 2024 · Learn about your options for treating multiple sclerosis (MS), including different types of disease-modifying drugs, various therapies, and lifestyle changes. Comparative Apr 9, 2025 · Apr 09, 2025 - Discover the latest advances in multiple sclerosis (MS) treatments, including mesenchymal stem cell therapy, clinical trials, and symptom management strategies. Learn more about Gilenya May 8, 2025 · Medically Reviewed Know More: Understand Your MS Treatment Options Our experts explain what the latest developments in therapies could mean for multiple sclerosis. S. Multiple sclerosis (MS) is a neurological disease that affects the brain and spinal cord. Oct 29, 2024 · The newest drugs for the treatment of multiple sclerosis include Briumvi, Ponvory, Kesimpta, Bafiertam, Zeposia, Vumerity, Mavenclad, Mayzent, and Ocrevus. Today, UC San Francisco’s discoveries are keeping millions with MS healthier for longer – many disability-free. pkd2pxwtxom2ibp9kni2szukwqnbrsefyda5qketcemae